Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03042962 · ClinicalTrials.gov registry record
Brain Networks in Dystonia
A clinical trial of Spasmodic Dysphonia and Singer's Dystonia, sponsored by Massachusetts Eye and Ear Infirmary.
- Recruiting
- Registry status
- 141
- Enrollment target
- 1
- Study location
NCT03042962: Recruiting study of Spasmodic Dysphonia and Singer's Dystonia, sponsored by Massachusetts Eye and Ear Infirmary.
NCT03042962 is a study of Spasmodic Dysphonia and Singer's Dystonia that is actively recruiting participants, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 141 participants, above the 94-participant average among 7 other Spasmodic Dysphonia trials with a reported enrollment target (50% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03042962, a study of Spasmodic Dysphonia and Singer's Dystonia, is actively recruiting participants, sponsored by Massachusetts Eye and Ear Infirmary.
- RECRUITING
- Registry status
- 141 participants
- Enrollment target
- 1
- Study location
Study Summary
To date, there is only limited knowledge about the distinct neural abnormalities that lead to the development of different forms of focal dystonia. The goal of this study is to dissect the pathophysiological mechanisms underlying this clinical phenomenon using multi-level brain network analysis in patients with focal dystonia.
Primary Outcome
Identify changes in brain activity and gray and white matter in patients with dystonia vs. unaffected relatives vs. healthy controls
Conditions Studied
Interventions
- OTHER MRI
- PROCEDURE Blood draw
Study Locations (1)
Massachusetts
- Massachusetts Eye and Ear - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2015-08-01 |
| Est. Completion | 2027-12-31 |
What NCT03042962 shows while recruiting
NCT03042962 is an observational study that tracks outcomes without assigning an intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, above the 94-participant average among 7 other Spasmodic Dysphonia trials with a reported enrollment target (50% higher).
The record links to 6 conditions, with Spasmodic Dysphonia appearing as the primary indexed condition, and to 2 interventions - of which MRI is the first listed.
NCT03042962 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03042962 about?
NCT03042962 is a clinical study titled "Brain Networks in Dystonia". To date, there is only limited knowledge about the distinct neural abnormalities that lead to the development of different forms of focal dystonia. The goal of this study is to dissect the pathophysiological mechanisms underlying this clinical phenomenon using multi-level brain network analysis in p...
What is the current status of trial NCT03042962?
This trial is currently recruiting. The enrollment target is 141 participants. The study started on 2015-08-01. Estimated completion is 2027-12-31.
What conditions does trial NCT03042962 study?
This clinical trial studies the following conditions: Spasmodic Dysphonia, Singer's Dystonia, Writer's Cramp, Musician's Focal Hand Dystonia, Craniofacial Dystonia.
What interventions are being tested in trial NCT03042962?
The interventions under investigation include: MRI (OTHER), Blood draw (PROCEDURE).
Who is sponsoring clinical trial NCT03042962?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03042962 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spasmodic Dysphonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor
RECRUITING
-
Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor
RECRUITING · Early Phase 1
-
Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor
RECRUITING · NA
-
Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia
ACTIVE NOT RECRUITING · Phase 1
-
Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia
COMPLETED
-
Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04378439 · 141 participants · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
- NCT05814146 · 141 participants · NA
Trial of Variable Dialysate Bicarbonate
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI